Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
New 52-week high today, $36.48, backed off since ~ 10:15 am.
* * $INSM Video Chart 02-04-2020 * *
Link to Video - click here to watch the technical chart video
* * $INSM Video Chart 02-03-2020 * *
Link to Video - click here to watch the technical chart video
Blueyedcatch,
Are you still around?
Yesterday was a great day for insmed!
GLTU
FTR
Very exciting times for Insmed. Great data,,major expansion app potential,,Japan totally in the works,and ready to be submitted once the data is ready, and translated. KaChing. 300 a share is not a stretch by any means for Insm,going forward. Next years a big year.
Thanks for the encouragement. I will wait for a pullback. Or for the RSI to get back down to 50 or so. If I miss it, so be it. It looks a bit top heavy to me right now. GLTU
Oxnous,
I just think you're in time.
Take you're time to do some dd.
You will find out this is going a lot higher..,
http://files.shareholder.com/downloads/INSMED/399897590x0x690054/37e9b63d-74e7-4892-965b-a0ea6fb7cccf/INSMED-IR-Deck.pdf
See slide 6-7
Approval is around the corner....
Ahh yes,,but Gottlieb is transforming the FDA to make approval or disapproval times much faster. The FDA wants Arikace approved and so does the CDC,and everyone who`ll benefit from the drug. We`re getting approved,IMO,and we`re just waiting for the FDA letter to go before the FDA panel for our majority yes vote. I really want to hear about Iplex,because that`s icing on the cake big time,and no one`s expecting anything out of it,so that news breaks and we run a bunch more. I`m with Pianoman and others of long term,on where the share price should get to after approval,but throw in iplex and we`re definitely over 100-125.
I will continue to monitor for news. I have been burned too many times by the FDA--FDA taking too long before eventual approval.
And the FDA NOT approving a drug.
But, that is why there is a potential high return. Because there definitely high risk.
GLTU
Iplex is free and clear for Insm from the settlement in October,next month.Not sure if it`s clear October 1st or the 31st.
Been a long time. Was the drug involved there Iplex and the DNA patent one of Cabiily that evolved from an interference DNA lost in PTO but won in settlement in D.Ct.? That DNA/Roche patent should be about to expire, if it hasn't already expired.
In since DNA patent battle that was settled....sold off a 1/3 of shares for LTCG in SEP-IRA, other 2/3 remain there
PGA$. Worked good today for me :).
Knew this was pumped and would head down soon enough
Thank you JK.
Blueyedcatch,
Sorry I don't have an account to post..
Just lurking...
Can you do us a favor and post a message over there and tell them to come over here? I`d like to hear what Pianoman is saying these days. Thanks in advance. Oh,don`t tell terry,we don`t want him over here.
Reluctant,
Welcome back...
I'm still here since 2001...
The other oldies are on InvestorVillage...
GLTY
Anyone here from the "old days"?
2008 ish?
Wow that`s a lot of cash. More than enough extra to get Iplex going again. 377 million plus cash on hand,which is probably around 60 mln. They said 75 on the call,but that was for the end of June,so they`ve probably spent some of that 75 mln since,and that`s where I get the 60 mln. So a grand total of 430 mln minimum,and certainly a company in a position to start the new year off with super strength. Will Lewis has stated several times that he plans to turn Insmed into a stand alone big pharma,with multiple App`s for Arikace,and we`re hoping Iplex reborn,or another acquisition of a late stage drug,who knows. Point is the companies situated perfectly to achieve what Lewis declared he would do.Is it a ploy to sell Insm for the highest price possible?or is he really gonna do it?
Insmed Announces Closing of Public Offering - https://finance.yahoo.com/news/insmed-announces-closing-public-offering-200100479.html
Thanks man. Did you take a look at $CLF$. Yet? Do you think it could reach $20 or higher in the next 2 years?
I am happy for you great work
I'm out at. 30.25. From 24. Quick three day. 6k
I`m wondering how fast, with the new FDA under Gottleib,we will see approval,especially when the CDC wants what we have, as well as the FDA practically holding Insmeds hand through this whole thing. Everyone wants it approved,so it`s just a question of how long. IMO,the EU will get us done for sure,and the FDA should be a gimme considering everything. So how long? Shorts aren`t gonna get anything because approval could happen anytime now,and the offering set the bottom while we wait for it.
good luck hope it works for you
Trailing stop man. Trying to make some money back I lost in GIG$. I'm up 7k. If my stop hits I will make 5k . Nothing is long term
this was pumped up to sell shares good luck holding this one
After the offering they will have around 450 million in cash and they have 55 million in debt and burning around 38 million a quarter. I have a trailing stop on this one. :)
There is no revenue yet but and approved by FDA yet but I would be careful shorting this jk. If approved watch this move up quickly . Of course very risky. I only own 1k shares. Got at $24. We will see.
Nonsense pure nonsense. Its not an FDA approval no revenue pump and dump. Shorting this POS
Only around 12 millions shares. This is a game changer. If they can pull in 1.6 billion a year on this and give it a x15 multiple. =. That is a 24 billion market cap. That is a 366. 96 a share
Plenty of working capital! INSM is a great $$$$$ opportunity.
I TRIED GETTING FILLED
THEY WOULDNT FILL ME, SO I GAVE UP LOL
Canceled Buy 1000 INSM Limit 29.69 -- 09/07/17 10:18:25 09/07/17
Canceled Buy 1000 INSM Limit 29.60 -- 09/07/17 10:18:16 09/07/17
Canceled Buy 1000 INSM Limit 29.50 -- 09/07/17 10:17:52 09/07/17
That`s a lot of cash for? IPLEX?
Investors here are forward looking and loading INSM shares.
$350M+ Wow! This company is in fantastic cash position going forward. With the high volume sessions this week, that cash could be raised in three hours. Smart management!
That`s right,,I talked to a bunch of big boys about it and they thought it would be 25.00 a share. I was hoping for 29.-29.50,but 28.50 is still big enough to wreck shorts by the way side. Any that are shorting here hoping for a pullback,are playin with fire. Upgrades with inflated price targets are certainly on the way.
$28.50 is higher than some thought http://ih.advfn.com/p.php?pid=nmona&article=75594881&symbol=INSM
Stand sad he missed the bottom... hehe
Followers
|
93
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
6485
|
Created
|
11/30/02
|
Type
|
Free
|
Moderators |
Old summary was from PRIOR to insmed taking over Transave.
Transave website:
Insmed old lead drug iplex is still being run in an external trial on Retinopathy in premature infants. Trial is fully stocked with iplex to complete phase 2b
http://www.rop.gu.se/prevention/
And there is still expanded acces program with iplex in ALS patients in italy with limited supply of iplex into 2011.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |